GRK2 is a novel early marker of cardiotoxicity in response to doxorubicin
20 April 2018 (00:00 - 00:00)
Organised by: 

About the speaker

Federico II University Hospital, Napoly (Italy)
51 More presentations in this session
Mr C. Perdios (Nottingham, GB)
Miss E. Fotiou (Manchester, GB)
Doctor A. Golovkin (Saint Petersburg, RU)
Access the full session
The Event
Frontiers in CardioVascular Biology 2018
20 April - 22 April 2018



